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Background: Particle size is thought to be a critical factor affecting the bioavailability of nanoparticles following
oral exposure. Nearly all studies of nanoparticle bioavailability focus on characterization of the primary particle size
of the material as supplied or as dosed, and not on agglomeration behavior within the gastrointestinal tract, which
is presumably most relevant for absorption.
Methods: In the study reported here, snapshots of agglomeration behavior of gold nanospheres were evaluated
in vivo throughout the gastrointestinal tract using transmission electron microscopy. Agglomeration state within the
gastrointestinal tract was then used to help explain differences in gastrointestinal particle absorption, as indicated
by tissue levels of gold detected using inductively coupled plasma mass spectrometry. Mice were dosed (10 mg/kg)
with either 23 nm PEG-coated or uncoated gold nanospheres.
Results: Transmission electron microscopy demonstrates that PEG-coated gold nanoparticles can be observed as
primary, un-agglomerated particles throughout the gastrointestinal tract and feces of dosed animals. In contrast,
uncoated gold nanoparticles were observed to form agglomerates of several hundred nanometers in all tissues
and feces. Inductively coupled plasma mass spectrometry shows significantly higher levels of gold in tissues from
animals dosed with PEG-coated versus uncoated 23 nm gold nanoparticles. Retention of particles after a single
oral gavage was also very high, with all tissues of animals dosed with PEG-coated particles having detectable
levels of gold at 30 days following exposure.
Conclusions: Qualitative observation of these particles in vivo shows that dispersed PEG-coated particles are able
to reach the absorptive tissues of the intestine while agglomerated uncoated particles are sequestered in the
lumen of these tissues. However, the large differences observed for in vivo agglomeration behavior were not
reflected in oral absorption, as indicated by gold tissue levels. Additional factors, such as surface chemistry, may
have played a more important role than in vivo particle size and should be investigated further.
Keywords: Agglomeration, Gastrointestinal uptake, Gold nanoparticles, In vivo characterizationBackground
The projected market value for nanotechnology prod-
ucts is expected to exceed $3 trillion this year, with over
1,000 consumer goods currently available containing
nanomaterials [1,2]. Applications for these materials that
may lead to oral exposure are continuing to expand and
currently include food additives, food packaging, phar-
maceuticals, natural supplements and personal care
products [3-7]. Many of these food additives and other
products have been used for decades with micron-sized* Correspondence: georgia.hinkley@nih.gov
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unless otherwise stated.particles, however newer products are engineering smaller
particles to increase product effectiveness. It is estimated
that humans are orally exposed to micron and nano-sized
particles at a rate of approximately 40 mg per day, mostly
consisting of sub-micron sized silica and TiO2 [1,8]. Due
to the increased use of nanomaterials in consumer prod-
ucts, it is important to assess the potential for toxico-
logical interactions. As a first step, the factors influencing
their gastrointestinal uptake must be understood.
Trends affecting gastrointestinal absorption of nano-
materials have been investigated largely with latex and
polystyrene particles. These materials can easily be made
to have fluorescent properties, making the localization of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have shown that primary particle size is an important
determinant for location of gastrointestinal uptake
[9,10]. Evidence has been provided that 50 nm and
100 nm particles can be taken up via enterocytes in the
upper small intestine, while larger particles (up to
500 nm) are taken up via Peyer’s Patches (PPs) in the
lower small intestine [1,10]. However, a study by Jani
et al. provides evidence that larger particles, up to 1 μm
were able to achieve PP uptake. Particles with a diameter
of 1 μm or less were reportedly found to translocate to
the mesenteric lymph nodes after PP uptake and eventu-
ally reached the spleen via lymphatic circulation. Parti-
cles smaller than 1 μm were then able to exit the spleen
via unknown mechanisms, leaving the 1 μm particles se-
questered there. Qualitative investigations of particle up-
take in the gastrointestinal tract (GIT) have also been
performed with gold nanoparticles (AuNPs), showing
that passive uptake during cell turnover is a primary
mechanism of absorption [11]. While these studies offer
evidence for size-dependent mechanisms of uptake, they
provide little quantitative data on the uptake of ingested
particles.
Some studies have quantitatively investigated the oral
absorption of nanomaterials (i.e., their bioavailability),
but insight regarding the influence of size is con-
founded by incomplete particle characterization. No
studies to date have analyzed in vivo particle character-
istics in situ following oral exposure and related them
to the extent of particle uptake. Changes in effective
particle size are likely to occur in vivo within the
gastrointestinal tract due to agglomeration, especially
in the harsh pH of the stomach and strong ionic condi-
tions throughout the gastrointestinal tract. As the ef-
fective particle size at the absorptive surfaces of the
GIT increases with agglomeration, size-dependent up-
take is likely to be influenced. Many studies associate
their bioavailability results with characterization of the
“as-dosed” material, but the in vivo agglomeration state
of the nanoparticles has largely been ignored as a factor
affecting particle uptake.
We report here the results of a study using transmis-
sion electron microscopy to relate snapshots of agglom-
eration behavior of gold nanoparticles in the GIT and to
particle uptake. Gold was chosen for this study because
it is electron dense and can be readily visualized by
transmission electron microscopy (TEM), facilitating de-
tection of particles in complex biological environments
such as the gastrointestinal tract. It is also resistant to
dissolution in physiological fluids (including the low pH
of gastric fluids) and has a low background concentra-
tion in tissues. This allows the intact gold nanoparticle
content of tissues to be measured in a relatively straight-
forward manner by determining gold concentrations byinductively coupled plasma mass spectrometry (ICP-
MS).
It was hypothesized that polyethylene glycol-coated
(PEG-coated) and uncoated 23 nm gold spheres would
display contrasting agglomeration behavior following
oral administration, with uncoated gold extensively ag-
glomerating while the PEG-coated nanoparticles remained
dispersed. We further hypothesized that agglomeration of
uncoated gold nanoparticles would result in diminished
uptake from the GIT as compared with PEG-gold. To test
these hypotheses, a single gavage dose of either uncoated
or PEG-coated gold nanoparticles to mice and the in vivo
agglomeration state of each was observed, beginning in
the stomach and continuing in each organ (small intestine,
cecum, large intestine) until excretion. Uptake was evalu-
ated by measuring gold concentrations in tissues over
time following gavage. This study represents, to the best
of our knowledge, the first attempt to relate particle up-
take behavior in vivo to agglomeration state as it exists at
potential absorptive sites within the GIT.
Results
Particle characterization
The TEM analysis indicated that the synthesized gold
nanoparticles were spherical with an average primary
particle size of 14 nm ± 2 nm (Figure 1A, B). The par-
ticle surface area was calculated to be 22.2 m2/g. To esti-
mate the surface area per mass, the surface area per
particle was divided by the mass per particle. The sur-
face area per particle was calculated with the assumption
that the particles are spherical, using the equation for
the surface area of a sphere (SA = 4πr2). The mass per
particle was calculated with the assumption that the parti-
cles are spherical using the density of gold (19.3 g/cm3)
and the equation for the volume of a sphere (V = 4/3* πr3).
Based on the mass concentration of the dosing solution
(1.5 mg/mL as measured using ICP-MS following aqua
regia digestion), and the mass per particle calculations, the
dosing solution contained 5.4 x 1013 particles/ml. Dynamic
light scattering (DLS) was used to determine hydro-
dynamic diameter of the as dosed materials, revealing the
uncoated particlesto have a distribution centered around
23 nm± 6 nm while the PEG-coated particles had a distri-
bution centered around 45 nm± 2 nm (Figure 1C).
Particle agglomeration and dissolution in a simulated
gastric environment
Both PEG-coated and uncoated particle suspensions
were stable in water. However, when placed in simulated
gastric fluid (SGF), the uncoated gold particles agglom-
erated immediately, reaching sizes over 800 nm in two
hours, while the hydrodynamic diameter of the PEG-
coated particles remained unchanged even after 24 hours
in SGF (Figure 2A). The difference in agglomeration
Figure 1 Particle characterization: TEM and dynamic light scattering. Transmission electron micrograph of PEG-coated (A) and uncoated (B)
gold nanospheres. One-hundred particles were measured for each particle type to determine the average primary particle size to be 14 ± 2 nm.
Dynamic light scattering particle size distributions of the as dosed PEG-coated and uncoated particles (C) measured the hydrodynamic diameter
of the particles to be 45 ± 2 nm and 23 ± 6 nm, respectively.
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particles types in water and in simulated gastric fluid
after 5 minutes, 2 hours and 24 hours (Figure 2B). Little
change is observed for PEG-coated particles even after
24 hours in SGF, while the uncoated particles visibly
change after 5 minutes in SGF and have agglomerated so
extensively after 2 hours that they have settled out of
suspension. Particle size distributions of the particles in
water and in simulated gastric fluid at 5 minutes and
2 hours are shown in Figure 2C (PEG-coated particles)
and Figure 2D (uncoated particles). To confirm the ab-
sence of dissolution of gold particles under gastric con-
ditions, uncoated particles were incubated in SGF for
5 hours. Measurement of gold in ultrafiltrate following
incubation found that only 0.003% of the mass of gold
nanoparticles incubated was present as gold ions (data
not shown).Oral bioavailability and particle uptake into tissues
Mice were orally gavaged with either PEG-coated or
uncoated 23 nm gold spheres (10 mg/kg in water), and
tissues and feces were collected and analyzed using
ICP-MS to quantify oral uptake of PEG-coated and un-
coated 23 nm gold spheres. Significantly higher levels
of gold were detected in the liver and heart of animals
dosed with PEG-coated versus uncoated particles at six
hours post-gavage (Table 1). Twenty-four hours post-
gavage, higher gold concentrations were observed for
several tissues of animals dosed with PEG-coated vs.
uncoated gold nanoparticles: blood, spleen, kidney,
heart, lung and brain (Table 1). Differences in the
amount of gold detected in liver at six hours were no
longer significant at 24 hours post-gavage, suggesting
redistribution of absorbed particles during the first
24 hours following dosing. Redistribution patterns of
Figure 2 PEG-coated and uncoated 23 nm gold nanoparticle behavior in simulated gastric fluid. Dynamic light scattering was used to
show the agglomeration behavior of PEG-coated and uncoated 23 nm gold nanoparticles in simulated gastric fluid during 2 hours of incubation
at 37°C. Figure 2A shows both particle types over the 2 hour time course; uncoated gold nanoparticles agglomerate immediately while PEG-coated
particles remain well dispersed in simulated gastric fluid. Figure 2B shows photographs of PEG-coated and uncoated gold particles in water
and in simulated gastric fluid after 5 minutes, 2 hour and 24 hours. As seen using DLS, PEG-coated particles remain well dispersed and appear
as they do in water while uncoated particles agglomerate extensively. The particle size distributions for the particles in water and in SGF at
5 minutes and 2 hours are also shown for PEG-coated (Figure 2C) and uncoated particles (Figure 2D).
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particles are shown in Figure 3A and B, respectively, at
6, 12 and 24 hours post-gavage. The level of gold in
blood increased over the first 24 hours, while gold
levels in the liver significantly decreased over this time
period for mice dosed with either particle type.
The retention of absorbed particles 30 days following a
single oral gavage was also investigated. Gold was de-
tected in all tissues of mice treated with PEG-coated
gold particles and many tissues of mice treated with
uncoated particles. These data demonstrate high reten-
tion of absorbed particles, even after an acute exposure
(Figure 4). It is very interesting to note that there
remained a relatively high amount of gold in all tissues
of the GIT (stomach, small intestine, cecum and large
intestine) at 30 days post-gavage. For Table 1 and
Figures 3 and 4, it is important to emphasize that the
data are expressed in terms of total gold per tissue in
nanograms. While significant differences were observedbetween the particle types, the values detected in the tis-
sues of animals given either dosing solution are more than
three orders of magnitude less than the total administered
dose (300 μg): demonstrating very poor oral absorption of
either particle type.
In vivo agglomeration
Mice were dosed as previosuly described and the in vivo
agglomeration behavior of the particles was investigated
throughout the GIT (stomach, ileum/PP region, cecum,
large intestine and feces) using TEM. For these experi-
ments, tissue and lumen contents were fixed to allow
visualization of the location of particles in the lumen
relative to cells lining the GIT, as well as to prevent
agglomeration artifacts during sample preparation.
The impact of TEM processing on particle suspension
stability within tissues cannot be predicted, however, it
is likely much less dramatic than the artifacts that are
known to exist for TEM preparation of particle
Table 1 Total gold content of tissues 6, 12 and 24 hours following oral exposure to gold nanoparticles
6 Hour 12 Hour 24 Hour
Total Au content (ng) Total Au content (ng) Total Au content (ng)
(SD) (SD) (SD)
PEG-coated Uncoated PEG-coated Uncoated PEG-coated Uncoated
Blood 22.2 18.7 38.1 13.2 227.1* 93.8
(5.0) (6.7) (26.2) (2.2) (120.6) (32.5)
Liver 378.1** 103.0 162.3 89.1 21.2 19.1
(166.9) (12.1) (81.8) (20.6) (3.7) (3.7)
Spleen 3.8 9.4 18.2 2.2 15.3** 11.1
(1.0) (14.6) (18.9) (0.8) (2.3) (1.4)
Kidney 13.1 9.3 19.3 9.5 13.6*** 9.3
(2.5) (1.3) (10.8) (1.1) (1.9) (1.2)
Heart 219.1** 10.4 40.6** 9.0 21.6*** 6.1
(155.5) (3.3) (15.0) (1.7) (6.9) (0.7)
Lung 5.5 66.1 12.4 3.7 4.4*** 2.9
(0.4) (124.9) (10.0) (1.0) (0.8) (0.1)
Testes 2.5 3.1 4.9 2.4 2.3 2.4
(0.2) (1.1) (4.8) (0.3) (0.5) (0.4)
Brain 1.8 0.9 3.8 1.0 1.5** 0.6
(0.3) (0.1) (3.6) (0.3) (0.5) (0.1)
Asterisks indicate statistically significant differences in total gold content for tissues from mice dosed with PEG-coated versus uncoated gold particles for each time
point. * indicates a p-value≤ 0.05, ** indicates a p-value≤ 0.01 and *** indicates a p-value ≤ 0.005. For all groups, averages are based on n = 5, and standard deviations
are shown in parentheses below each average.
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a diagram of the GIT with five inset images (I-V) repre-
senting snapshots of agglomeration behavior of PEG-
coated and uncoated particles in the stomach (I), small
intestine (II), cecum (III), large intestine (IV) and feces
(V). PEG-coated gold particles are frequently observed
as primary/un-agglomerated particles near the tissue
surface of the stomach (Figure 5-IA). In contrast, the
majority of the observed mass dose of uncoated gold
particles was found only in the lumen of the stomach
as agglomerates (Figure 5-IB). This pattern was also
seen in the Peyer’s patch region of the ileum; unag-
glomerated PEG-coated particles in Figure 5-IIA can be
seen interacting with microvilli adjacent to the dome
region of a PP, while uncoated gold particles were pri-
marily located in the lumen of the ileum as large ag-
glomerates, approximately 4 μm from the tissue surface
(Figure 5-IIB). Figure 5-IIC shows the ileal microvilli of
a mouse dosed with uncoated gold particles at the same
time point, demonstrating that the tissue surface was
observed to be void of particles. The agglomeration be-
havior in the cecum was similar; PEG-coated particles
were found near the tissue surface as primary particles
(Figure 5-IIIA) and uncoated particles were observed as
agglomerates in the cecum lumen, 5 μm from the tissue
surface (Figure 5-IIIB). The pattern changed somewhatin the colon, where both particle types were found only
in the lumen of the large intestinal approximately
10 μm from the tissue surface (Figures 5-IVA and C).
However, as seen in the other GIT organs, the agglom-
eration behavior in the large intestine remains as previ-
ously described. Figure 5-IVB shows the thick mucin
layer present in the large intestine which may have pre-
vented either particle type from migrating to the tissue
surface. Finally, agglomeration behavior was investi-
gated in excreted feces. The feces from mice dosed with
PEG-coated particles contained loose agglomerates,
likely the result of dehydration in the colon, as well as
several primary particles (Figure 5-VA), while the ma-
jority of particles in the feces of mice dosed with un-
coated gold were found as densely packed agglomerates
(Figure 5-VB). Composition of the imaged particles was
confirmed to be gold using energy-dispersive X-ray
spectroscopy (Figure 6).
Discussion
While the data presented here show significant differ-
ences for gold content in tissues, suggesting higher ab-
sorption of PEG-coated versus uncoated gold particles,
both particle types had very low absorption with less
than 1% of the administered dose being found in tissues,
cumulatively. Other groups have demonstrated low
Figure 3 Tissue concentrations of PEG-coated1 (A) and uncoated (B) 23 nm gold spheres 6, 12 and 24 hours post-gavage. Total gold
measured in tissues and blood six, twelve and twenty-four hours following oral gavage of PEG-coated (A) and uncoated (B) 23 nm AuNPs suspended
in water. Gold was measured using ICP-MS. Data are presented as average ± SD, n = 5. Statistical significance: * indicates a p-value≤ 0.05, ** indicates a
p-value≤ 0.01 and *** indicates a p-value≤ 0.005. 1Particle size given for PEG-coated particles is reflective of the gold core, the hydrodynamic diameter
of the PEG-coated particles was determined to be 45 nm.
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Schleh and coworkers [12] administered a single oral
gavage dose of TPPMS-coated 198Au nanoparticles to
rats, with nanoparticle sizes ranging from 1.4 to 200 nm;
the percent dose recovered in feces and found in GIT
contents was >99.6 for all particle sizes, suggesting that
oral bioavailability was very low. Although nanoparticles
eliminated in the feces could theoretically include parti-
cles that were absorbed and eliminated in the bile, other
studies of gold nanoparticles administered by intraven-
ous injection have shown that biliary excretion of gold
nanoparticles is minimal, around 5% for either PEG-
coated or uncoated small (<10 nm) gold nanoparticles in
rats [13,14]. The absence of significant biliary excretionindicates that gold nanoparticles appearing in feces are
reasonable estimates of unabsorbed material.
The very low oral bioavailability of gold nanoparticles
observed in rats by Schleh and coworkers over a wide
nanoparticle size range is consistent with results shown
here. Extensive agglomeration of uncoated gold through-
out the gastrointestinal tract observed in this study
could explain the low absorption of the uncoated gold
nanoparticles presented in this study, as well as the low
bioavailability of the particles studied by Schleh and
others. However, the poor absorption of the PEG-coated
particles was more surprising. Simulated gastric incuba-
tions indicated rapid agglomeration of uncoated gold
nanoparticles, while PEG-coated gold nanoparticles
Figure 4 Tissue concentrations of PEG-coated1 and uncoated
23 nm gold spheres 30 days post-gavage. Total gold measured
in tissues and blood thirty days following oral gavage of PEG-coated
and uncoated 23 nm AuNPs suspended in water. Gold was measured
using ICP-MS. Data are presented as average ± SD, n = 5. Statistical
significance: * indicates a p-value≤ 0.05, ** indicates a p-value≤ 0.01
and *** indicates a p-value≤ 0.005. 1Particle size given for PEG-coated
particles is reflective of the gold core, the hydrodynamic diameter of
the PEG-coated particles was determined to be 45 nm.
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was also observed through snapshots of in vivo agglom-
eration behavior using TEM. PEG-coated 23 nm gold
nanoparticles were observed as un-agglomerated pri-
mary particles throughout the GIT, and were frequently
found adjacent to the absorptive surfaces of the GIT tis-
sues. In contrast, uncoated 23 nm gold nanoparticles
were found almost entirely as large agglomerates located
away from GIT epithelial surfaces. TEM sections from
the GIT, while observing many more particles in the
lumen near epithelial lining in animals dosed with PEG-
coated particles, showed almost no particles absorbed
into the GIT tissues in animals given either uncoated or
PEG-coated particles.
The presence of a thick protective layer of mucin coat-
ing the GIT is likely responsible for limiting access of
the agglomerated uncoated particles to these tissue sur-
faces. Particle size has been shown to be influential in
determining the ability of a particle to move through the
mucin layer, which can be as thick as 100 μm in humans
and 30–50 μm in rats [15,16]. Goblet cells maintain this
protective mucus with complete turnover of the mucin
layer every 4–6 hours [17,18]. For particles to reach ab-
sorptive surfaces they must transit the entire mucin layer
during this time frame. Smaller particles move through
the layer most rapidly, and based on experimental data,
particles ≥ 1 μm are immobile in mucin [16]. Other
groups have shown that PEG surface coating is favorable
for efficient mucin movement, probably due to neutral
zeta potential [19]. It is important to note however, thatsimilar to the importance of in vivo size measurements,
it would be difficult to draw conclusions about the im-
pact of surface charge without in vivo characterization.
The PEG surface coating used in this study may have
aided the increased uptake of those particles; however, it
is also likely that the large agglomerate sizes of the un-
coated particles played a role in inhibiting their uptake.
Another important consideration for the role of the
protective mucin layer is that the PP region of the small
intestine is devoid of goblet cells and has very dimin-
ished mucus production, allowing interaction of the GIT
immune cells with ingested materials [20]. Consistent
with this, a previous study with fluorescent polystyrene
particles has shown PP uptake of 1 μm particles [10]. In
the study reported here, we did not see large agglomer-
ates of uncoated gold nanoparticles interacting with the
PP regions of the small intestine. However, the TEM
analysis used in this study served to provide a snapshot
of agglomeration behavior throughout the GIT; without
quantitative analysis, this type of interaction with gold
nanoparticle agglomerates cannot be ruled out.
While PEG-coating may have potentially been advan-
tageous to transit the thick mucin layer, there is evidence
that PEG-coating can decrease macrophage uptake of
iron particles and that longer chain lengths increase uptake
hindrance [21]. Other groups have shown that coating
nanoparticles with various materials (food or immune-
related) can influence their uptake into cells and the impact
of PEG-coating on intestinal absorption should be investi-
gated further [22-24]. In addition, PEG-coating undoubt-
edly changed the surface charge (not measured here) of the
particles compared to an uncoated gold surface. This
change in surface charge may have further enhanced the
difference in protein corona between the particle types.
While PEG-coating is a mechanism to prevent agglomer-
ation, certain aspects of the particle surface chemistry will
be changed, possibly preventing the adsorption of surface
macromolecules that facilitate absorption.
Conclusions
When evaluating particle characteristics that influence
their uptake, agglomeration state within the GIT must
be assessed and taken into consideration. By focusing on
particle behavior at the site of absorption more meaning-
ful conclusions can be reached about factors influencing
oral bioavailability as compared to studies that only con-
sider the “as dosed” characterization data. Gold nanoparti-
cles can be readily detected and their agglomeration
behavior and surface properties can be manipulated, mak-
ing them valuable tools with which to explore factors con-
trolling uptake from the gut. This study suggests that
agglomeration behavior and effective particle size within
the gastrointestinal tract may not be a significant factor
for the oral bioavailability of gold nanomaterials, however,
Figure 5 (See legend on next page.)
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Figure 5 TEM images of PEG-coated and uncoated 23 nm gold spheres throughout the gastrointestinal tract. TEM images of gold
nanospheres found throughout the gastrointestinal tract of a mouse following oral gavage: in the stomach (I) 10 minutes post-gavage (PG), small
intestine (II) 2.5 hours PG, cecum (III) 4 hours PG, large intestine (IV) 5 hours PG and feces (V) 24 hours PG. Micrographs from animals gavaged
with PEG-coated particles are shown in panel A for all five insets, uncoated particles are shown in panel B for all insets except IV (large intestine)
in which uncoated particles are shown in panel C. As seen in snap shots throughout the GIT, PEG-coated particles remain well dispersed while
uncoated particles appear to agglomerate extensively, beginning immediately after dosing, as seen in the stomach (I). In addition to a contrast in
agglomeration behavior, PEG-coated particles are frequently seen adjacent to the absorptive surfaces within the GIT (I-III) while uncoated particles
are only observed in the tissue lumen, distal from the surface (I-IV). As seen in the small intestine (II), panel C shows the microvilli of a mouse
dosed with uncoated particles being entirely void of particles. In image IV, large intestine, the thick mucin layer can be seen in panel B, potentially
explaining why both PEG-coated and uncoated particles were only observed in the lumen of the tissue.
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not be discounted as a factor affecting bioavailability of
nanomaterials. Additional studies, quantitatively analyzing
events occurring in situ at absorptive surfaces of the gut,
will be needed to better understand the relationship of
particle properties and nanoparticle bioavailability.
Methods
Materials
All reagents used for particle synthesis of PEG-coated
and uncoated gold nanospheres were purchased from
Fisher Scientific (Pittsburgh, PA, USA). All materials
used for transmission electron microscopy tissue pro-
cessing were purchased from Electron Microscopy Sci-
ences (Hatfield, PA, USA). All components of the
simulated gastric fluid, nitric acid, hydrochloric acid, and
hydrogen peroxide were purchased from Fisher Scien-
tific (Pittsburgh, PA, USA). Hydrophilic PTFE (polytetra-
fluoroethylene) 0.22 μm filters for ICP-MS analysis were
purchased from MilliPore™ (Billerica, MA, USA).
Nanoparticle preparation and characterization
Spherical gold particles with a nominal particle size of
23 nm were synthesized by citrate reduction of gold
chloride as described previously [25]. These particlesFigure 6 Energy-dispersive X-ray spectroscopy. Energy-dispersive X-ray
4 hours following oral gavage. The presence of peaks from Al and Cu origiwere washed and concentrated by centrifugation. A por-
tion of the uncoated particles were then reacted with ex-
cess thiol-terminated polyethylene glycol (5 kDa) to
achieve PEG-coating. All particles were characterized
with a Tecnai™ Spirit transmission electron microscope
(FEI Company, Hillsboro, OR, USA), operated at
110 keV, to verify particle size and shape. Dynamic light
scattering was used to determine hydrodynamic diameter
and particle size distribution on a Brookhaven ZetaPlus in-
strument (Brookhaven Instruments Corp., Holtsville NY).
Values indicated for particle size distributions are average
diameter ± reproducibility of the measurement.
Simulated gastric fluid incubations and dissolution
Characterization of 23 nm uncoated gold particles in
simulated gastric fluid was performed using dynamic
light scattering on a Brookhaven ZetaPlus instrument
(Brookhaven Instruments Corp., Holtsville NY). Simu-
lated gastric fluid (SGF) was prepared as previously de-
scribed [26]. Particle dissolution was investigated after
5 hours in simulated gastric fluid at 37°C. Particles were
removed by high speed centrifugation and the super-
natant was tested for gold ions using inductively coupled
plasma mass spectrometry on a Thermo Electron X
Series II (Thermo Scientific, West Palm Beach, FL,
USA).spectroscopy of 23 nm uncoated gold nanoparticles in the cecum
nate from the specimen holder and grid respectively.
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Adult male (25–30 g) ICR outbred mice were purchased
from Harlan Laboratories (Pratville, AL). Prior to dosing,
mice were housed in cages (five mice per cage), with
controlled light/dark cycles of 12 hours (08:00–20:00
light). Temperature (18–26°C) and humidity (30–70%)
were also controlled. Animals were fed a standard diet
(Tekland Rodent Diet 7912, Harlan Laboratories) and
were fasted 10 hours prior to oral gavage and 2 hours
post oral gavage; animals always had free access to water.
Mice were given an oral gavage of 10 mg/kg of either
PEG-coated or uncoated 23 nm gold nanoparticles in
200 μl of MilliQ™ water. The dose of 10 mg/kg was se-
lected as a mid-range dose based on the literature, with
other studies ranging from less than 1 mg/kg to 300 mg/
kg. Actual administered dose was not quantified for each
animal. Dose was estimated using a simulated gavage in-
jection to estimate retention of dosing solution; the ad-
ministered dose ranged from 99.5 to 101% of the desired
dose. Following oral gavage, mice were placed in glass
metabolism cages for collection of samples at the 6, 12
and 24 hour time points, while mice dosed for the
30 day time point were kept in metabolism cages for
5 days and then returned to standard housing for the
duration of the experiment. Urine and feces were col-
lected from metabolism cages. For ICP-MS analysis,
mice were euthanized at 6, 12, 24 hours and 30 days
post oral gavage using carbon dioxide inhalation and
cervical dislocation. Tissues and blood (cardiac punc-
ture) were collected following euthanasia and acid
digested for ICP-MS analysis. For TEM analysis, mice
were euthanized by carbon dioxide inhalation and cer-
vical dislocation and tissues were collected at various
time points (details below). This study was approved by
the Institutional Animal Care and Use Committee, and
all animals were treated humanely according to criteria
provided in the NIH “Guide for the Care and Use of La-
boratory Animals”.
Transmission electron microscopy
For the TEM analysis portion of this study, a total of 10
animals were used. One animal was investigated for each
pairing of sample type (stomach, small intestine, cecum,
large intestine and feces) and particle solution (uncoated
and PEG-coated gold spheres). For the small intestine
investigation, the PP region was selected due to evidence
that this region may be more important for uptake of
“larger particles” [1,10]. Specific tissue processing details
for each sample type are described below.
Stomach and cecum tissue processing
Fasted animals were dosed (10 mg/kg) with either a
23 nm PEG-coated or uncoated gold particle solution.
Five minutes and 4 hours following oral administration,for stomach and cecum respectively, animals were eu-
thanized with carbon dioxide inhalation. Following eu-
thanasia, a large ventral incision was made to expose the
abdominal cavity and heart. The hepatic portal vein was
cut to be utilized as a drain and then a 24 gauge catheter
was inserted into the left ventricle of the heart and
clamped in place. The mouse was then perfused with
0.1 M sodium cacodylate buffer (0.1 M cacodylate buffer,
2 mM MgCl2,1 mM CaCl2, 2.5% NaCl, pH 7.24), con-
tinuing for five minutes after the hepatic drain appeared
to be blood-free. The perfusion was then switched to a
2% glutaraldehyde/ 4% paraformaldehyde solution in
0.1 M sodium cacodylate buffer. Following complete
perfusion, the stomach and cecum were dissected and
placed into 15 mL of fresh 2% glutaraldehyde/ 4% para-
formaldehyde fixative in 0.1 M sodium cacodylate buffer.
Additional fixative was then injected slowly into the
lumen of the stomach via the duodenum and lower
esophageal sphincter using a syringe. Samples remained
at room temperature (25°C) for 1 hour and were then
held at 4°C overnight. The following morning, samples
were transferred into fresh 0.1 M sodium cacodylate buf-
fer and microwaved at 220 watts (PELCO Biowave
Microwave Processor, Ted Pella Inc, Redding, CA, USA),
under vacuum (15–20 mmHg), for 30 seconds, followed
by 1 minute at room temperature; this was repeated
twice with fresh buffer. Next, the stomach was gently
cut with a scalpel and slices were placed on glass slides
and embedded in warm agarose while sitting on ice.
After the agarose was set and became gelatinous, sam-
ples were returned to 0.1 M sodium cacodylate buffer.
Buffer was then replaced with a 2% OsO4 solution in
0.1 M sodium cacodylate buffer and then microwaved
(180 Watts, lower wattage used for OsO4 only) under
vacuum for 30 seconds, followed by 3 minutes at room
temperature. Osmium tetroxide solution was removed
and samples were placed in double distilled water
(ddH2O) and microwaved with vacuum for 30 seconds,
followed by 1 minute at room temperature; this was re-
peated twice with fresh ddH2O. Samples were then in-
troduced to an ethanol series (in water) for dehydration:
25%, 30%, 40%, 50%, 60%, 75%, 80%, 90% and 100%
twice. Samples were microwaved for 45 seconds (without
vacuum), followed by 5 minutes at room temperature
for each step. Ethanol was then replaced with 100% acet-
one and microwaved (without vacuum) for 45 seconds,
followed by 5 minutes at room temperature; this was
then repeated once with fresh 100% acetone. Next, sam-
ples were moved to a Spurr’s resin series (in acetone):
25%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 100% twice.
Spurr’s resin was supplemented with 100 μl/10 ml of Z-
6040, used as a primer, and 2-dimethylaminoethanol
(DMAE), used as an accelerator. During each step of the
Spurr’s series, samples were microwaved for 3 minutes,
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100% Spurr’s were left at room temperature for 1 hour.
Samples in 25%–60% Spurr’s were microwaved without
vacuum, while samples in 70%–100% Spurr’s were micro-
waved under vacuum. Samples were left in 100% Spurr’s,
covered with parafilm and placed on a rocker overnight at
room temperature. The next morning, samples were
moved to a resin mold and placed in fresh 100% supple-
mented Spurr’s resin. Molds were vacuumed to remove
air bubbles and then placed at 60°C for 72 hours to ensure
complete resin hardening.
Ileum (PPs), large intestine and feces processing
Due to the small size of these tissues, samples were col-
lected immediately following euthanasia and did not re-
quire whole animal perfusion. Animals were dosed
(10 mg/kg) with either 23 nm PEG-coated or uncoated
gold spheres and then tissues were collected. Ileum sam-
ples were collected 2.5 hour post oral gavage, colon sam-
ples were collected at 5 hour post oral gavage and feces
were collected 24 hours post oral gavage. Samples
(~2 mm in length) were placed directly into a 2% glutaral-
dehyde/ 4% paraformaldehyde solution in 0.1 M sodium
cacodylate buffer and processed as described above for
stomach and cecum. The only difference being that these
samples did not require agarose embedding, due to their
smaller size.
Sectioning, staining, imaging
Samples were sectioned at 70–100 nm using a LEICA
Ultracut UCT microtome (Leica Microsystems, Wetzlar,
Germany). Sections were collected on uncoated 3 mm
copper grids and stained with uranyl acetate and lead
citrate before viewing on a Tecnai™ Spirit transmission
electron microscope (FEI Company, Hillsboro, OR,
USA) operated at 110 keV.
Energy-dispersive X-ray Spectroscopy
Analysis of the elemental composition was performed on
a section of cecum from a mouse treated with uncoated
gold by use of a JOEL6335F SEM (JOEL USA, Inc, USA)
operated at 15 kV. This instrument was equipped with
an Oxford ISIS EDS system (Oxford Instruments plc, UK).
Inductively coupled plasma mass spectrometry
The Thermo Electron X Series II (Thermo Scientific,
West Palm Beach, FL, USA) was used for all ICP-MS
analyses, with indium as an internal standard. The LOD
was 0.1 ppb, with an LOQ of 1 ppb. Procedural blanks
were run in conjunction with all samples and subtracted
as background. All groups (two particle dosing groups
and four time points) were run with an n = 5. One
vehicle-control group (water only, 24 hours), n = 5, was
used to measure background gold. The gold detected inall control animals was below the level of quantitation
(<1 ppb in any single tissue). The total number of ani-
mals used for bioavailability measurements was 45 (n = 5
for controls, n = 5 x 2 particle groups x 4 time points).
Stomach, small intestine, cecum, feces
Due to potential fecal contamination of urine samples in
metabolism cages, urine and feces were combined after
collected and dried at 60°C overnight. Stomach, small in-
testine, cecum and dried feces were weighed (±0.1 mg)
and microwave digested using Xpress vessels in 10 mL
of trace metal grade nitric acid. Microwave digestion
(Mars Xpress by CEM Corporation of Matthews, NC,
USA) was done using a max temperature control of 200°
C with 1600 W of available power. Samples were ramped
to 200°C over a period of fifteen minutes and then held
at 200°C for fifteen minutes. This microwave cycle was
run between 1 and 6 times until samples were com-
pletely digested. Digested samples were then placed in
18 mm x 150 mm borosilicate tubes and dried down at
140°C. Hydrogen peroxide (300 μl) was then added to
each sample at 125°C and dried down to a final volume
of 200 μl at 140°C. Gold was then digested by adding
300 μl of aqua regia, vortexed for 15 seconds, diluted to
6 mL with MilliQ™ water and filtered using 0.22 μm
hydrophilic PTFE membrane filters; feces samples were
diluted to 50 mL with MilliQ™ water to ensure gold
values fell within the standard curve.
Brain, heart, lung, spleen, kidney, liver, large intestine,
testes, blood
These tissues were weighed (±0.1 mg) and digested with
2 mL of nitric acid in open 16 mm x 150 mm borosili-
cate tubes at 140°C. Samples were heated for varying
lengths of time depending on tissue type until digested.
Hydrogen peroxide (300 μl) was then added to each
sample at 125°C and dried down to a final volume of
200 μl at 140°C. Gold was then digested by adding
300 μl of aqua regia, vortexed for 15 seconds, diluted to
6 mL with MilliQ™ water and filtered using 0.22 μm
hydrophilic PTFE membrane filters.
Statistical analysis
Sigma Plot 11.0 (Systat Software Inc., Chicago, IL, USA)
was used for statistical analysis. All results are presented
as averages (n = 5) of the total amount of gold (ng) de-
tected in a given organ, ± the standard deviation. Nor-
mality was tested using the Shapiro-Wilk test. All data
passed a test of normality and differences between
groups were detected using parametric tests. The stu-
dents t-test was used to detect significant differences be-
tween two groups (Figure 4), while one-way ANOVA
was used to detect differences between several groups
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roni correction. A p-value < 0.05 was considered statisti-
cally significant.
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